The global obesity GLP-1 market size accounted for USD 8.21 billion in 2025 and is predicted to increase from USD 10.12 billion in 2026 to approximately USD 66.57 billion by 2035, expanding at a CAGR of 23.28% from 2026 to 2035
Many patients do not realize that dehydration is a GLP-1 side effect, but obesity medicine physicians are routinely screening for dehydration at follow-up visits, says Reema Dbouk, MD, assistant professor of medicine at Emory University in Atlanta and a spokesperson for The Obesity Society
STEP 1 Health Assessment Create a profile with your name, contact information, and address
Users can access detailed information about weight loss mechanisms , safety profiles , and dosing protocols
Frequently Asked Questions About Sermorelin and HGH How quickly will I see results from Sermorelin therapy
Resveratrol suppresses cross-talk between colorectal cancer cells and stromal cells in multicellular tumor microenvironment: A bridge between in vitro and in vivo tumor microenvironment study